CO42 Efficacy and Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Treatment of Anaemia of Chronic Kidney Disease: A Systematic Literature Review

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.121
https://www.valueinhealthjournal.com/article/S1098-3015(22)02325-7/fulltext
Title : CO42 Efficacy and Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Treatment of Anaemia of Chronic Kidney Disease: A Systematic Literature Review
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02325-7&doi=10.1016/j.jval.2022.09.121
First page :
Section Title :
Open access? : No
Section Order : 10775
Categories :
Tags :
Regions :
ViH Article Tags :